- 2021 American Transplant Congress - Body Mass Index >35 Does Not Impact Kidney Transplant Outcomes or Health Related Quality of Life Despite BMI Class or Recipient Race*Purpose: Kidney transplant [KTx] in recipients with BMI > 35 remains controversial and has not often been studied in recipients with BMI >40. There is…
- 2021 American Transplant Congress - Ganciclovir Therapeutic Drug Monitoring in Obese Adults Patients – Opportunity for Clinical Utility*Purpose: Ganciclovir (GCV) is the drug of choice for the treatment of cytomegalovirus (CMV) infection; optimal dosing of GCV in the obese patient population is…
- 2021 American Transplant Congress - Outcomes of Simultaneous Kidney-Pancreas Transplantation in Patients with Type-I and Type-II Diabetes Mellitus*Purpose: UNOS approved simultaneous kidney-pancreas transplantation (SKPT) for type-II diabetes mellitus (DM) in Oct 2014. There is limited data comparing outcomes of SKPT in type-I…
- 2021 American Transplant Congress - Attitudes of Obese Kidney Transplant Candidates Towards Bariatric Surgery- Surgery, University of Illinois Hospital & Health Sciences System, Chicago, IL *Purpose: Obesity is an epidemic in the US and increasingly prevalent in kidney transplant candidates. Surgical weight-loss interventions are effective and reduce transplant-related complications. They…
- 2021 American Transplant Congress - Predictors of Postoperative Atrial Fibrillation in an Urban, Obese Adult Renal Transplant Population- University of Illinois at Chicago, Chicago, IL *Purpose: Postoperative atrial fibrillation (POAF) is a common surgical complication. Renal transplant (RT) recipients possess risk factors that may lead to a higher incidence of…
- 2021 American Transplant Congress - Evaluation of Empiric Extended-Release Tacrolimus Dosing in Adult Kidney Transplant Recipients- Pharmacy, NewYork-Presbyterian Hospital, New York, NY *Purpose: Envarsus XR® (extended-release [XR] tacrolimus) is the standard of care tacrolimus formulation at our center for de novo maintenance immunosuppression in adult kidney transplant…
- 2021 American Transplant Congress - Obesity Impacts Acute Rejection but Not Allograft Function Improvement in the Setting of Belatacept Conversion- University of Illinois at Chicago, Chicago, IL *Purpose: There is limited data regarding belatacept conversion in obese patients as an alternative to calcineurin inhibitor (CNI) immunosuppression. Pharmacokinetic (PK) data suggests increasing clearance…
- 2021 American Transplant Congress - Application of Incisional Wound Vac to Decrease Wound Complications and Surgical Site Infections: A Single Center Pilot Project- University of Rochester Medical Center, Rochester, NY *Purpose: Wound complications and surgical site infections (SSIs) are common but morbid complications of transplant in immunosuppressed patients. Kidney transplant patients who are obese, highly…
- 2021 American Transplant Congress - Nutrition, Body Habitus, and Food Insecurity, in Pediatric Kidney Transplant Recipients- 1Emory University, Atlanta, GA, 2Emory University and Children's Healthcare of Atlanta, Atlanta, GA *Purpose: Appropriate nutrition and physical activity are critical for optimal post-transplant recovery and long term outcomes, especially in pediatric populations. Both malnutrition and obesity are…
- 2021 American Transplant Congress - Obesity is a Risk Factor for Progression to Kidney Transplant Waitlisting After Liver Transplantation*Purpose: Non-alcoholic steatohepatitis (NASH) has emerged as a leading cause of cirrhosis, and obesity-associated comorbid conditions, including renal disease have become more prevalent. Obesity predisposes…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 24
- Next Page »
